Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jan 15;16(2):209-21.
doi: 10.1101/gad.942302.

kuzbanian-mediated cleavage of Drosophila Notch

Affiliations

kuzbanian-mediated cleavage of Drosophila Notch

Toby Lieber et al. Genes Dev. .

Abstract

Loss of Kuzbanian, a member of the ADAM family of metalloproteases, produces neurogenic phenotypes in Drosophila. It has been suggested that this results from a requirement for kuzbanian-mediated cleavage of the Notch ligand Delta. Using transgenic Drosophila expressing transmembrane Notch proteins, we show that kuzbanian, independent of any role in Delta processing, is required for the cleavage of Notch. We show that Kuzbanian can physically associate with Notch and that removal of kuzbanian activity by RNA-mediated interference in Drosophila tissue culture cells eliminates processing of ligand-independent transmembrane Notch molecules. Our data suggest that in Drosophila, kuzbanian can mediate S2 cleavage of Notch.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagram of N constructs and localization of epitopes recognized by antibodies. (A) The antibodies used in this work, above the regions of N used to generate them, and the region of N fused to GST (BD) used in the pull-down assays in Figure 2B. The top molecule in B is wild-type N tagged with the DNA-binding domain of LexA, NLexA. (S) Signal sequence; (EGF) epidermal growth factor-like repeats; (LNG) Lin-12, N, Glp-1 repeats; (S2) location of TACE cleavage site in mammals; (S3) location of Psn-dependent cleavage site; (TM) transmembrane domain; (nls1, nls2) nuclear localization signals; (CDC10) cdc10 or ankyrin repeats; (polyQ) polymeric glutamines; (PEST) PEST sequence thought to be involved in protein stability. Shown beneath NLexA are the various deletions used in this work.
Figure 2
Figure 2
Kuz can associate with N. (A) S2 cells transfected with actin-driven N alone (lanes 1,4) or with actin N plus actin-driven myc-tagged kuz (lane 2) or kuzDN (lane 3) were immunoprecipitated with anti-myc (lanes 13) or anti-NI (lane 4) antibodies, and the Western probed with anti-NPCR antisera. See Figure 1A for location of the epitopes recognized by the antibodies. (B) Bacterially produced GST–N fusion protein encoding amino acids 1623–1893 of N (from the end of the LNG repeats to the start of the ankyrin repeats, BD in Fig. 1A) was used in pull-down assays of in vitro translated Su(H) (lane 3), Kuz (lane 6) and human insulin receptor (hIR, lane 9) labeled with 35S methionine. (I) 1% of the input in vitro translation product; (V) GST alone; (N) GST–N fusion.
Figure 3
Figure 3
A comparison of the activities of LNLexA and LNRLexA. (AE) The effect that expressing NLexA (A), LNLexA (B,C), or LNRLexA (D,E) under control of daughterless (da) GAL4 (a ubiquitous driver) has on the nervous system of wild-type embryos. (A,B,D) Ventral views; (C,E) lateral views. The embryos were stained with an anti-horseradish peroxidase (HRP) antibody that reacts with the nervous system. (F) Western blot showing increased production of Npp114LexA in embryos expressing LNRLexA. Extracts of embryos expressing NLexA (lanes 1,2), LNLexA (lanes 3,4), or LNRLexA (lanes 5,6) under the control of daGAL4 were immunoprecipitated with anti-Su(H) antisera, and the Western was reacted with anti-LexA antisera. The immunoprecipitates in lanes 2, 4, and 6 were treated with phosphatase prior to electrophoresis. NLexA is the full-length N protein that coimmunoprecipitates with Su(H); Npp114LexA is the phosphorylated cleaved cytoplasmic domain that associates with Su(H); and Np100LexA is the phosphatased cytoplasmic domain that associates with Su(H) (Kidd et al. 1998). (GI) The increase in nuclear entry of the cytoplasmic domain derived from LNRLexA. S2 cells were transfected with UAS constructs encoding NLexA, LNLexA, or LNRLexA, and a plasmid encoding heat shock (hs) GAL4 at a ratio of 1:10. Cells were heat-shocked for 30 min and allowed to recover for 2 h prior to fixation. They were then reacted with the NT antibody, which reacts with the extracellular domain; the NPCR antibody, which reacts with the intracellular domain; and sytox green to label the DNA. See Figure 1A for location of the epitopes recognized by the antibodies. (J,K) embryos expressing NLexA (J) or LNRLexA (K) under control of daGal4 were reacted with anti-LexA antibody to detect the N protein derived from the transgene and propidium iodide, which reacts with the DNA.
Figure 4
Figure 4
Signaling from LNLexA and LNRLexA is decreased in the absence of Dl. (AD) Embryos expressing LNLexA (A), LNRLexA (B), and NIntraLexA (C,D) under control of daGAL4, reacted with anti-HRP antibody. The embryo in C is Dl+, the other three are zygotic Dl nulls. The same transgenic lines were used in wild-type (Fig. 3B–E; Fig. 4C) and Dl backgrounds. Of the three antineurogenic N proteins, NIntraLexA produces the strongest antineurogenic phenotype in a wild-type background. (E) Extracts of embryos expressing NLexA (lanes 1,2), LNLexA (lanes 3,4), and LNRLexA (lanes 5,6) under control of daGAL4, in either wild-type (lanes 1,3,5) or zygotic Dl backgrounds (lanes 2,4,6), were immunoprecipitated with anti-Su(H) antibody and the Western reacted with anti-LexA antibody. To ensure that the protein being characterized is derived from Dl embryos, both the N transgenes and daGAL4 were recombined onto Dl chromosomes.
Figure 5
Figure 5
Signaling from LNLexA and LNRLexA is decreased in the absence of Kuz. All the embryos (AE) were reacted with anti-HRP antibody. (A) Ventral view of an embryo that is maternally and zygotically kuz null. (BE) The effect of expressing in a maternal and zygotic kuz background NLexA (B), LNLexA (C), LNRLexA (D), and NIntraLexA (E). All the N proteins were expressed under control of daGAL4. The white stars in E point out the remnants of the nervous system in kuz; NIntraLexA embryos. The same transgenic lines were used in wild-type (Fig. 3A–E; Fig. 4C) and kuz backgrounds. (F) Extracts of embryos expressing NLexA (lanes 1,2), LNLexA (lanes 3,4), and LNRLexA (lanes 5,6) under control of daGAL4, in either wild-type (lanes 1,3,5) or maternal and zygotic kuz backgrounds (lanes 2,4,6) were immunoprecipitated with anti-Su(H) antibody and the Western reacted with anti-LexA antibody. To ensure that the protein being characterized is derived from kuz embryos, the N transgenes were recombined onto kuz chromosomes.
Figure 6
Figure 6
Anti-N immunoprecipitates of extracts from Dl and kuz embryos differ. (A) Extracts of embryos expressing NLexA (lanes 2,3), LNLexA (lanes 4,5), and LNRLexA (lanes 6,7), under the control of daGAL4 were immunoprecipitated with anti-NI antibody (see Fig. 1A) and the Western reacted with anti-LexA antibody. Extracts of embryos expressing NLexA were also immunoprecipitated with anti-Su(H) antibody (lane 1). The immunoprecipitates in lanes 1, 3, 5, and 7 were treated with phosphatase prior to electrophoresis. Np100LexA is the phosphatased cytoplasmic domain that interacts with Su(H) (Kidd et al. 1998). (S2 ●) Migration of S2-cleaved N; (S3 *) migration of S3-cleaved N; (S) Su(H); (▴ in lanes 2,3) an ∼97-kD cleavage product present in NI immunoprecipitates of extracts expressing NLexA that does not associate with Su(H), but is dependent on Psn (see text); (○ in lanes 5,6) an ∼108-kD cleavage product found in NI immunoprecipitates of LNLexA. (B) Extracts of embryos expressing NLexA (lanes 13), LNLexA (lanes 46), and LNRLexA (lanes 79), under the control of daGAL4, which had been fractionated into membrane and soluble fractions, were immunoprecipitated with anti-NI antibody and the Western reacted with anti-LexA antibody. (T) Unfractionated extract; (M) membrane fraction; (So) soluble fraction. All immunoprecipitates were phosphatased prior to electrophoresis. (C) Extracts of embryos expressing LNRLexA under the control of daGAL4 were fractionated into membrane, cytoplasmic, and nuclear fractions prior to immunoprecipitation with anti-NI antibody. The immunoprecipitates in lanes 2, 4, and 6 were phosphatased. The Western was reacted with anti-LexA antibody. (M) Membrane; (C) cytoplasm; (N) nuclear. The smear representing phosphorylated S3 in the nuclear fraction (lane 5) is more easily visible on longer exposures. (D,E) Extracts of embryos expressing NLexA were immunoprecipitated with anti-NI antibody (D, lanes 1–5; E, lanes 2–7) and the Western reacted with anti-LexA antibody. The extracts in lanes 1 and 5 of D and lanes 2 and 5 of E were from wild-type embryos (WT). The extracts in lane 2 of D and lanes 3 and 6 of E were from zygotic Dl embryos. The extracts in lane 3 of D and lanes 4 and 7 of E were from maternal and zygotic kuz embryos. The extract in lane 4 of D was from maternal and zygotic Psn embryos. (D, lane 6; E, lane 1) Extracts of NLexA embryos were also immunoprecipitated with anti-Su(H) antibody (S). The immunoprecipitates in lanes 4 and 5 of D were derived from embryos expressing NLexA under the control of armadillo (arm) GAL4. All the other immunoprecipitates were derived from embryos expressing NLexA under the control of daGAL4. (▴ in D, lanes 1,2,5; E, lanes 2,3,5,6) The NLexA derived protein that is dependent on Psn but does not associate with Su(H). (E, lanes 57) A longer exposure of lanes 24. (S2* in E) The N cleavage product the size of S2-cleaved N that is found in kuz extracts but is not processed further (see text). (F,G) Comparisons of the anti-NI immunoprecipitates of WT (lane 3), Dl (lane 4), kuz (lane 5), and Psn (lane 6) embryos expressing LNLexA (F) and LNRLexA (G). In lanes 1 and 2 extracts of embryos expressing NLexA were immunoprecipitated with anti-Su(H) antibody (S) and anti-NI antibody respectively. (G, lane 7) extracts of Psn embryos expressing NLexA were immunoprecipitated with anti-NI antibody. (G*) S3-cleaved N. All the immunoprecipitates in DG were phosphatased prior to electrophoresis. To ensure that the protein being characterized is derived from Dl embryos, both the N transgenes and daGAL4 were recombined onto Dl chromosomes and to ensure that the protein being characterized is derived from kuz and Psn embryos, the N transgenes were recombined onto kuz and Psn chromosomes, respectively. All the immunoprecipitates within each panel (AG) were electrophoresed on the same gel. In some of the panels different exposures of the lanes were used to generate the figure. Only the regions where the S2 and S3 cleavage products migrate are shown.
Figure 6
Figure 6
Anti-N immunoprecipitates of extracts from Dl and kuz embryos differ. (A) Extracts of embryos expressing NLexA (lanes 2,3), LNLexA (lanes 4,5), and LNRLexA (lanes 6,7), under the control of daGAL4 were immunoprecipitated with anti-NI antibody (see Fig. 1A) and the Western reacted with anti-LexA antibody. Extracts of embryos expressing NLexA were also immunoprecipitated with anti-Su(H) antibody (lane 1). The immunoprecipitates in lanes 1, 3, 5, and 7 were treated with phosphatase prior to electrophoresis. Np100LexA is the phosphatased cytoplasmic domain that interacts with Su(H) (Kidd et al. 1998). (S2 ●) Migration of S2-cleaved N; (S3 *) migration of S3-cleaved N; (S) Su(H); (▴ in lanes 2,3) an ∼97-kD cleavage product present in NI immunoprecipitates of extracts expressing NLexA that does not associate with Su(H), but is dependent on Psn (see text); (○ in lanes 5,6) an ∼108-kD cleavage product found in NI immunoprecipitates of LNLexA. (B) Extracts of embryos expressing NLexA (lanes 13), LNLexA (lanes 46), and LNRLexA (lanes 79), under the control of daGAL4, which had been fractionated into membrane and soluble fractions, were immunoprecipitated with anti-NI antibody and the Western reacted with anti-LexA antibody. (T) Unfractionated extract; (M) membrane fraction; (So) soluble fraction. All immunoprecipitates were phosphatased prior to electrophoresis. (C) Extracts of embryos expressing LNRLexA under the control of daGAL4 were fractionated into membrane, cytoplasmic, and nuclear fractions prior to immunoprecipitation with anti-NI antibody. The immunoprecipitates in lanes 2, 4, and 6 were phosphatased. The Western was reacted with anti-LexA antibody. (M) Membrane; (C) cytoplasm; (N) nuclear. The smear representing phosphorylated S3 in the nuclear fraction (lane 5) is more easily visible on longer exposures. (D,E) Extracts of embryos expressing NLexA were immunoprecipitated with anti-NI antibody (D, lanes 1–5; E, lanes 2–7) and the Western reacted with anti-LexA antibody. The extracts in lanes 1 and 5 of D and lanes 2 and 5 of E were from wild-type embryos (WT). The extracts in lane 2 of D and lanes 3 and 6 of E were from zygotic Dl embryos. The extracts in lane 3 of D and lanes 4 and 7 of E were from maternal and zygotic kuz embryos. The extract in lane 4 of D was from maternal and zygotic Psn embryos. (D, lane 6; E, lane 1) Extracts of NLexA embryos were also immunoprecipitated with anti-Su(H) antibody (S). The immunoprecipitates in lanes 4 and 5 of D were derived from embryos expressing NLexA under the control of armadillo (arm) GAL4. All the other immunoprecipitates were derived from embryos expressing NLexA under the control of daGAL4. (▴ in D, lanes 1,2,5; E, lanes 2,3,5,6) The NLexA derived protein that is dependent on Psn but does not associate with Su(H). (E, lanes 57) A longer exposure of lanes 24. (S2* in E) The N cleavage product the size of S2-cleaved N that is found in kuz extracts but is not processed further (see text). (F,G) Comparisons of the anti-NI immunoprecipitates of WT (lane 3), Dl (lane 4), kuz (lane 5), and Psn (lane 6) embryos expressing LNLexA (F) and LNRLexA (G). In lanes 1 and 2 extracts of embryos expressing NLexA were immunoprecipitated with anti-Su(H) antibody (S) and anti-NI antibody respectively. (G, lane 7) extracts of Psn embryos expressing NLexA were immunoprecipitated with anti-NI antibody. (G*) S3-cleaved N. All the immunoprecipitates in DG were phosphatased prior to electrophoresis. To ensure that the protein being characterized is derived from Dl embryos, both the N transgenes and daGAL4 were recombined onto Dl chromosomes and to ensure that the protein being characterized is derived from kuz and Psn embryos, the N transgenes were recombined onto kuz and Psn chromosomes, respectively. All the immunoprecipitates within each panel (AG) were electrophoresed on the same gel. In some of the panels different exposures of the lanes were used to generate the figure. Only the regions where the S2 and S3 cleavage products migrate are shown.
Figure 7
Figure 7
A Dl-independent N protein requires kuz for activity. (AC) Ventral views of anti-HRP stains of embryos expressing ΔEGF 1–18 LNRLexA under control of daGAL4, in wild-type (A), Dl (B), or kuz (C) backgrounds. (D) Extracts of embryos expressing ΔEGF 1–18 LNRLexA under control of daGAL4 were immunoprecipitated with anti-NI antibody (lanes 2,3) or anti-Su(H) antibody (lanes 6,7). The extracts in lanes 2 and 6 are from wild-type embryos, and the extracts in lanes 3 and 7 are from Dl embryos. (Lane 1) An anti-NI immunoprecipitate of wild-type embryos expressing NLexA; (lanes 4,5) anti-Su(H) immunoprecipitates of embryos expressing NLexA. The immunoprecipitates in lanes 14 were treated with phosphatase. (*, lanes 2,3) S3-cleaved N; (●, lane 1) S2-cleaved N. (E) Extracts of embryos expressing ΔEGF 1–18 LNRLexA under control of daGAL4 were immunoprecipitated with anti-NI antibody (lanes 3,4) or anti-Su(H) antibody (lanes 6,7). The extracts in lanes 3 and 6 are from wild-type embryos, and the extracts in lanes 4 and 7 are from kuz embryos. (Lane 2) An anti-NI immunoprecipitate of wild-type embryos expressing NLexA; (lanes 1,5) anti-Su(H) immunoprecipitates of embryos expressing NLexA. The immunoprecipitates in lanes 14 were treated with phosphatase. (*, lane 3) S3-cleaved N. The Westerns in both D and E were reacted with anti-LexA antisera.
Figure 8
Figure 8
Kuzbanian promotes the cleavage of Notch. (A, lanes 312) are anti-NI immunoprecipitates of S2 cells expressing heat-shock-induced LNRKasLexA (see Fig. 1B) that have been treated with the indicated double-stranded (ds) RNAs. (Lane 2) An anti-NI immunoprecipitate of S2 cells expressing heat-shock-induced NKasLexA (see Fig. 1B); (lanes 1,13) anti-Su(H) immunoprecipitates of S2 cells expressing LNRKasLexA. (B, lanes 315) anti-NI immunoprecipitates of S2 cells expressing heat-shock-induced LNRKasLexA (lanes 311) or ΔEGF 1–18 LNRKasLexA (lanes 1215; see Fig. 1B) that have been treated with the indicated double-stranded (ds) RNAs. The cells in lanes 710 and 14 were cotransfected with an actin-driven TACE construct. (Lane 1) An anti-NI immunoprecipitate of S2 cells expressing heat-shock-induced NKasLexA; (lane 2) an anti-Su(H) immunoprecipitate of S2 cells expressing LNRKasLexA. All the immunoprecipitates were phosphatased prior to electrophoresis, and the Westerns were reacted with anti-LexA antisera. (S2, S3) Locations of S2 and S3 cleavage products.

References

    1. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: Cell fate control and signal integration in development. Science. 1999;284:770–776. - PubMed
    1. Blaumueller CM, Qi H, Zagouras P, Artavanis-Tsakonas S. Intracellular cleavage of Notch leads to a heterodimeric receptor on the plasma membrane. Cell. 1997;90:281–291. - PubMed
    1. Boulianne G, Livne-Bar I, Humphreys J, Liang Y, Lin C, Rogaev E, St George-Hyslop P. Cloning and characterization of the Drosophila presenilin homologue. Neuroreport. 1997;8:1025–1029. - PubMed
    1. Brennan K, Tateson R, Lieber T, Couso JP, Zecchini V, Martinez Arias A. The Abruptex mutations of Notch disrupt the establishment of proneural clusters in Drosophila. Dev Biol. 1999;216:230–242. - PubMed
    1. Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, Cumano A, Roux P, Black RA, Israël A. A novel proteolytic cleavage involved in Notch signaling: The role of the disintegrin-metalloprotease TACE. Mol Cell. 2000;5:207–216. - PubMed

Publication types